Ambulatory Continuous Adductor Canal Block to Facilitate Same Day Discharge Following Total Knee Arthroplasty: A Pilot Study

Sponsor
Lawson Health Research Institute (Other)
Overall Status
Completed
CT.gov ID
NCT02228759
Collaborator
(none)
25
1
1
8
3.1

Study Details

Study Description

Brief Summary

Patients scheduled to undergo total knee arthroplasty will receive motor sparing knee blocks with continuous adductor canal block along with multimodal analgesia started pre-operatively and continued into the postoperative period. The study will evaluate the feasibility of home discharge within the first 24 hours following total knee arthroplasty. We will also evaluate the pain scores in the first 5 days following the surgery, causes of delayed discharge and any adverse events.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Adductor canal block
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
25 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Study Start Date :
Apr 1, 2015
Actual Primary Completion Date :
Dec 1, 2015
Actual Study Completion Date :
Dec 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: Adductor canal block

The study is an open label pilot study to determine the feasibility of same day discharge following total knee arthroplasty with the use of a fast track regimen employing motor sparing knee blocks. The study will be performed on 25 American Society of Anesthesiologists class (ASA) 1-2 patients satisfying the inclusion criteria and undergoing unilateral primary total knee arthroplasty. First and second patients of the day undergoing surgery between Monday to Thursday in a week will be accessed for the study.

Procedure: Adductor canal block
All patients will recieve fast tracking with reduced fasting times, multimodal analgesia and adductor canal block

Outcome Measures

Primary Outcome Measures

  1. percentage of patients discharged at 23 hours based on a composite of various factors represented on a pre-determined criteria [24 hours]

Secondary Outcome Measures

  1. first 24 hour pain scores [24 hours]

  2. first 96 hour pain scores [96 hours]

  3. Rescue analgesic frequency [24 hours]

  4. total analgesic usage in the first 24 and 96 postoperative hours [96 hours]

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Male and females of 40-70years of age

  2. Scheduled to undergo unilateral primary total knee arthroplasty

  3. ASA Class I, II

Exclusion Criteria:
  1. ASA 3, 4

  2. Revision surgery

  3. Narcotic dependent (opioid intake morphine equivalent > 10 mg/ day for more than 3 months)

  4. Other sources of chronic pain like fibromyalgia

  5. Patients with associated significant cardiac, CNS or respiratory disease (poor cardio-respiratory reserve)

  6. Major conduction defects in EKG (bifascilular block, CHB); significant valvular heart disease

  7. Recent MI/ Stroke/ CHF (in the past 3 months)

  8. BMI> 35

  9. Obstructive sleep apnea (AHI > 15)

  10. Patients with coexisting hematological disorder or with deranged coagulation parameters.

  11. Patients with pre-existing major organ dysfunction such as hepatic and renal failure.

  12. Psychiatric illnesses

  13. Uncontrolled diabetes mellitus

  14. Lack of informed consent.

  15. Allergy to any of the drugs used in the study

  16. Preoperative neurological deficits

  17. Use of walking aids preoperatively

  18. Living alone (Lack of Chaperone/home help)

  19. Language barrier

  20. Contralateral leg weakness

  21. Pregnancy

Contacts and Locations

Locations

Site City State Country Postal Code
1 University hospital, London Health Sciences centre London Ontario Canada N6A 5A5

Sponsors and Collaborators

  • Lawson Health Research Institute

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Sugantha Ganapathy, Principal Investigator, Lawson Health Research Institute
ClinicalTrials.gov Identifier:
NCT02228759
Other Study ID Numbers:
  • 105097
First Posted:
Aug 29, 2014
Last Update Posted:
Mar 9, 2017
Last Verified:
Mar 1, 2017
Keywords provided by Sugantha Ganapathy, Principal Investigator, Lawson Health Research Institute
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 9, 2017